PTPRO and metabolic dysfunction-associated steatohepatitis: These results demonstrate PTPRO in hepatocytes, as a suppressor, plays a major role during NASH progression, while PTPROt in liver marcophages, as an enhancer of inflammation, is a supplementary regulating mechanism which also plays a significant role in NASH.